Tri-Domain Was Called Impossible. The Papers That “Prove” It Actually Prove NanoBase™ Right.
Every so often someone points at NanoBase™, cites a paper, and says a tri-domain carrier cannot exist. They are usually holding a real citation. Here is the part they miss: the papers are correct, and not one of them is about NanoBase™. Read them properly and they describe exactly why the architecture works.
The Emulsion They Said Couldn’t Exist: Inside the Tri-Domain Architecture of NanoBase™
In 1949, William Griffin published the Hydrophilic-Lipophilic Balance. Seventy-five years later, HLB still runs most of the cosmetic category — and it still does not account for surface charge, colloidal energy barriers, particle size, Ostwald ripening, or multi-carrier specificity. NanoBase™ was built to close those five gaps, simultaneously, on a single lecithin chassis.
NanoBase™ Rx: The Pharmacy Compounding Industry's Full Replacement for HLB Chemistry
NanoBase™ Rx is a pharmacy compounding excipient that combines a tri-domain nano-colloidal Architecture with a lyotropic liquid crystal matrix. Engineered at Pensive Beauty Labs. The three engineered nano-domains (lipophilic, hydrophilic, interfacial bridging) are designed to be organized within a biomimetic lamellar and bicontinuous cubic liquid crystal phase structure that matches the native liquid crystalline lamellar organization of stratum corneum intercellular lipids. Lamellar and cubic phase organization is a design target pending small angle scattering confirmation. Excipient only. No API supplied.
Nanoemulsion vs Nanoliposome vs Nanomicelle: Comparing Carrier Architectures for Cosmeceutical Delivery
Head-to-head technical comparison of three dominant nano-carrier architectures for cosmeceutical delivery: nanoemulsions (40 to 200 nm droplets), nanoliposomes (phospholipid bilayer vesicles), and nanomicelles (5 to 100 nm surfactant aggregates). Loading capacity, stability, stratum corneum penetration pathways, and why NanoBase™ tri-domain architecture from Pensive Beauty Labs outperforms single-class carriers.
The Architecture Era: Why Advanced Skincare Is No Longer About Ingredients
For decades, skincare innovation has been defined by ingredients. Retinol. Peptides. Growth factors. Exosomes. Each new molecule promised to be the breakthrough. But the real bottleneck was never the active list. It was the chassis carrying it.
In 2026, advanced skincare is no longer determined only by what’s inside the bottle. It’s shaped by the architecture that organizes and protects those actives in the formula. Without structural intelligence, even the most sophisticated molecules are forced to operate inside legacy systems built on outdated emulsion logic.
The next era of performance is not about stacking more ingredients. It’s about engineering the foundation first.
This is the architecture era.
NanoBase™ in Practice: A Practitioner Interview on Next-Generation Nano-Colloidal Architecture in Formulation
For decades, the skincare industry has relied on HLB logic designed for jar stability. In this practitioner interview, Med Spa Director Jaime Turgeon shares her professional observations of formulas built on NanoBase™, from formulating a 16% peptide load to "iteration velocity" in development. Her views are her informed professional opinion, not clinical evidence; every performance claim belongs to the finished formula.